These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1878960)

  • 1. [The specificity of plague antigen FI in PHA].
    Zhang HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Feb; 12(1):36-9. PubMed ID: 1878960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross reactions in PHA test for plague antibodies.
    Sehgal S; Singh S; Srivastava L; Gupta HO
    J Commun Dis; 1984 Dec; 16(4):317-9. PubMed ID: 6535790
    [No Abstract]   [Full Text] [Related]  

  • 4. Short report: Serodiagnosis of plague in humans and rats using a rapid test.
    Thullier P; Guglielmo V; Rajerison M; Chanteau S
    Am J Trop Med Hyg; 2003 Oct; 69(4):450-1. PubMed ID: 14640508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
    Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
    Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of monoclonal antibody to V antigen from Yersinia pestis.
    Sato K; Nakajima R; Hara F; Une T; Osada Y
    Contrib Microbiol Immunol; 1991; 12():225-9. PubMed ID: 1935094
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the results of 2-component serological reactions in plague depending on the quantitative relations between the complete and blocking components of the sample].
    Oganian EF; Filimonova IuA; Onatskaia TG
    Lab Delo; 1980; (4):246-7. PubMed ID: 6155558
    [No Abstract]   [Full Text] [Related]  

  • 9. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
    Elvin SJ; Williamson ED
    Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplague antibodies against Yersinia pestis fraction-I antigen in serum from rodents either experimentally infected or captured in harbor areas of Japan, 1971--1977.
    Suzuki S; Hotta S
    Microbiol Immunol; 1979; 23(12):1157-68. PubMed ID: 537520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
    Khan AA; Babu JP; Gupta G; Rao DN
    Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
    Leary SE; Eley SM; Williamson ED; Titball RW
    Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
    [No Abstract]   [Full Text] [Related]  

  • 15. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
    Elvin SJ; Williamson ED
    Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
    [No Abstract]   [Full Text] [Related]  

  • 16. The V antigen of yersiniae: an overview.
    Brubaker RR
    Contrib Microbiol Immunol; 1991; 12():127-33. PubMed ID: 1935079
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of serological tests for detecting antibody to plague.
    Williams JE; Atas M; Cavanaugh DC
    Bull World Health Organ; 1976; 54(2):232-3. PubMed ID: 1088106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
    Garmory HS; Freeman D; Brown KA; Titball RW
    Vaccine; 2004 Feb; 22(8):947-57. PubMed ID: 15161071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.